Abstract: The present invention provides to a process for recovery of an organic compound (i.e. Ethanol, propanol, butanol, Acetone, iso-propyl alcohol) from a fermented broth which is produced from different fermentation technologies. The present invention particularly relates to an integrated process for ethanol separation from the fermentation broth using integrated vapor compressing unit (turbofans), evaporator (falling film) and a broth stripper column (vacuum distillation system). The process is operated under low temperature for the separation and recovery of the organic compound (particularly ethanol) from the fermented broth containing live microbes typically below or at 50° C. to ensure the activity of the microbes in the broth recycle. Again, the activity of the microbes is further ensured by maintaining the residence time of the microbe containing broth outside the Fermentor is less than or equal to 10 minutes.

Abstract: The present invention provides to a process for recovery of an organic compound (i.e. Ethanol, propanol, butanol, Acetone, iso-propyl alcohol) from a fermented broth which is produced from different fermentation technologies. The present invention particularly relates to an integrated process for ethanol separation from the fermentation broth using integrated vapor compressing unit (turbofans), evaporator (falling film) and a broth stripper column (vacuum distillation system). The process is operated under low temperature for the separation and recovery of the organic compound (particularly ethanol) from the fermented broth containing live microbes typically below or at 50° C. to ensure the activity of the microbes in the broth recycle. Again, the activity of the microbes is further ensured by maintaining the residence time of the microbe containing broth outside the Fermentor is less than or equal to 10 minutes.

Abstract: Various systems and methods for restoring data using indexes. For example, one method involves receiving a request that includes a restore criterion. The method involves identifying a storage object in a backup storage device that meets the restore criterion, in response to the request. Detecting the identity of the storage object involves sending a query with the restore criterion to a client computing device that includes an index. The method also involves responding to the request with information identifying the storage object.

Abstract: The present invention provides a process for the preparation of oxcarbazepine of Formula (1), which is an Active Pharmaceutical Ingredient (API) and a useful intermediate in the preparation of eslicarbazepine acetate of Formula (A). The present invention further provides a process for the preparation of eslicarbazepine acetate.

Abstract: The present invention provides processes for the preparation of rivaroxaban. The present invention also provides an intermediate for the preparation of rivaroxaban.

Abstract: The present invention provides a novel process for the preparation of 10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide, commonly known as oxcarbazepine, which is a medicament and a useful intermediate in the preparation of eslicarbazepine acetate. The present invention further provides a process for the preparation and purification of eslicarbazepine acetate.

Abstract: Various systems and methods for restoring data using indexes. For example, one method involves receiving a request that includes a restore criterion. The method involves identifying a storage object in a backup storage device that meets the restore criterion, in response to the request. Detecting the identity of the storage object involves sending a query with the restore criterion to a client computing device that includes an index. The method also involves responding to the request with information identifying the storage object.

Abstract: The present invention relates to processes for reducing impurities in lacosamide during the preparation of lacosamide. The invention provides processes for minimizing or removing impurities such as (2R)-2-(acetylamino)-3-(benzylamino)-3-oxopropyl acetate of Formula II or (2R)-2-propanoylamino-N-benzyl-3-methoxypropionamide of Formula III in lacosamide.

Abstract: The present invention provides a novel process for the preparation of pure valganciclovir hydrochloride.

Abstract: The present invention relates to processes for reducing impurities in lacosamide during the preparation of lacosamide. The invention provides processes for minimizing or removing impurities such as (2R)-2-(acetylamino)-3-(benzylamino)-3-oxopropyl acetate of Formula II or (2R)-2-propanoylamino-N-benzyl-3-methoxypropionamide of Formula III in lacosamide.

Abstract: The present invention relates to processes for the preparation of crystalline polymorphic forms of lacosamide (Formula I), including processes for inter-conversion among such polymorphic forms.

Abstract: The present invention provides a novel process for the preparation of pure valganciclovir hydrochloride.

Abstract: The present invention relates to processes for the preparation of Form I and Form II of Ritonavir, wherein no seed crystals are used.

Abstract: The present invention relates to stable amorphous form of fexofenadine hydrochloride, process for its preparation, pharmaceutical composition comprising it and its use for the treatment of allergic reactions.

Abstract: A multistep process for producing 8-chloro-6-(2-fluorophenyl)-1-methyl-4-H-imidazo?1,5a!?1,4!benzodiazepine (midazolam) comprises treating a compound of Formula II with a lower alkyl dithiol to produce a compound of Formula III, wherein n=2 or 3, converting the compound of Formula III to a compound of Formula VII, and then treating the compound of Formula VII with a deprotecting agent, thereby producing midazolam. Novel intermediate compounds are also disclosed.

Abstract: A multistep process for producing 8-chloro-6-(2-fluorophenyl)-1-methyl-4-H-imidazo?1,5a!?1,4! benzodiazepine (midazolam) comprises treating a compound of Formula II with a lower alkyl dithiol to produce a compound of Formula III, wherein n=2 or 3, converting the compound of Formula III to a compound of Formula VII, and then treating the compound of Formula VII with a deprotecting agent, thereby producing midazolam. Novel intermediate compounds are also disclosed.